dacarbazine has been researched along with Hypopituitarism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atkins, MB; Gibney, GT | 1 |
| Chibbaro, S; Clavier, JB; Goichot, B; Lhermitte, B; Proust, F; Todeschi, J | 1 |
| Barlier, A; Barrie, M; Brue, T; Castinetti, F; Conte-Devolx, B; Dufour, H; Morange, I; Philippon, M; Taieb, D | 1 |
3 other study(ies) available for dacarbazine and Hypopituitarism
| Article | Year |
|---|---|
Swinging for the Fences: Long-Term Survival With Ipilimumab in Metastatic Melanoma.
Topics: Adrenal Insufficiency; Adult; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Dacarbazine; Hormone Replacement Therapy; Humans; Hypopituitarism; Hypothyroidism; Interferon-alpha; Interleukin-2; Ipilimumab; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Neoplasm Staging; Parietal Lobe; Radiosurgery; Sentinel Lymph Node Biopsy; Shoulder; Skin Neoplasms; Treatment Outcome; Vinblastine | 2015 |
An unusual pituitary stalk lesion: What is the place of surgery?
Topics: Adult; Antineoplastic Agents; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Diabetes Insipidus; Endoscopy; Fatal Outcome; Female; Hemianopsia; Humans; Hypopituitarism; Indoles; Melanoma; Pituitary Neoplasms; Sulfonamides; Temozolomide; Tomography, X-Ray Computed; Vemurafenib | 2016 |
Long-term control of a MEN1 prolactin secreting pituitary carcinoma after temozolomide treatment.
Topics: Adult; Antineoplastic Agents; Carcinoma; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Dopamine Agonists; Hormone Replacement Therapy; Humans; Hyperprolactinemia; Hypophysectomy; Hypopituitarism; Male; Multiple Endocrine Neoplasia Type 1; Mutation, Missense; Neoplasm Recurrence, Local; Ophthalmoplegia; Pancreatic Neoplasms; Parathyroid Neoplasms; Pituitary Apoplexy; Pituitary Neoplasms; Prolactin; Proto-Oncogene Proteins; Radiotherapy, Adjuvant; Remission Induction; Spinal Neoplasms; Temozolomide | 2012 |